New York, Oct. 25, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Women’s Health Therapeutics Industry” – https://www.reportlinker.com/p06033314/?utm_source=GNW
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year
Global Women’s Health Therapeutics Market to Reach $29.9 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Women’s Health Therapeutics estimated at US$12.2 Billion in the year 2020, is projected to reach a revised size of US$29.9 Billion by 2027, growing at a CAGR of 13.6% over the analysis period 2020-2027. Postmenopausal Osteoporosis, one of the segments analyzed in the report, is projected to record a 15.9% CAGR and reach US$11.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hormonal Infertility segment is readjusted to a revised 11.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 18.3% CAGR
The Women’s Health Therapeutics market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2027 trailing a CAGR of 18.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada,…
